Abstract
Cardiovascular disease is the most common cause of death in todays society. Heart transplantation is the only available treatment for patients suffering from end-stage congestive heart failure (CHF). Causes underlying the development of CHF are still unknown, but it has been suggested that proinflammatory cytokines play an important role. In the context of transplantation, proinflammatory T-helper 1 cytokines like TNF-α and IL-2 that mediate the cellular immune response are believed to be involved in acute graft rejection. On the other hand, Th2 cytokines, like IL-4, IL-6 and IL-10, induce tolerance, by down-regulating the Th1 response and cytokine production. Cytokine release by macrophages, lymphocytes and other cell types in the microenvironment of the graft, especially the balance between Th1 and Th2, is thought to be critical for the development of acute rejection. Production of cytokines has been shown to be under genetic control of single nucleotide polymorphisms (SNP) in mainly the promoter regions of cytokine genes. Genotypes of these SNP were shown to control the differential production of these cytokines, leading to a wide variety of cytokine patterns among individuals. Since levels of these cytokines affect the Th1 / Th2 balance, genotypes may be related to acute allograft rejection. Many studies have shown an association between cytokine gene polymorphisms and the development of several infections, allergies and autoimmune diseases. Also, associations between SNP in different cytokine genes and transplant rejection have been extensively studied. In our lab, SNP in the genes of TNF-α, TGF-β, IL- 4 and IL-10 were studied in a panel of 70 cardiac transplant patients and 61 of their donors. These data are discussed in the context of literature data.
Keywords: cytokine gene, gene polymorphism, heart transplantation, single nucleotide polymorphism, snp
Current Genomics
Title: Cytokine Gene Polymorphism in Heart Transplantation: A Review
Volume: 4 Issue: 3
Author(s): F. J. Bijlsma, A. H. Bruggink, F. H.J. Gmelig-Meyling and R.A. de Weger
Affiliation:
Keywords: cytokine gene, gene polymorphism, heart transplantation, single nucleotide polymorphism, snp
Abstract: Cardiovascular disease is the most common cause of death in todays society. Heart transplantation is the only available treatment for patients suffering from end-stage congestive heart failure (CHF). Causes underlying the development of CHF are still unknown, but it has been suggested that proinflammatory cytokines play an important role. In the context of transplantation, proinflammatory T-helper 1 cytokines like TNF-α and IL-2 that mediate the cellular immune response are believed to be involved in acute graft rejection. On the other hand, Th2 cytokines, like IL-4, IL-6 and IL-10, induce tolerance, by down-regulating the Th1 response and cytokine production. Cytokine release by macrophages, lymphocytes and other cell types in the microenvironment of the graft, especially the balance between Th1 and Th2, is thought to be critical for the development of acute rejection. Production of cytokines has been shown to be under genetic control of single nucleotide polymorphisms (SNP) in mainly the promoter regions of cytokine genes. Genotypes of these SNP were shown to control the differential production of these cytokines, leading to a wide variety of cytokine patterns among individuals. Since levels of these cytokines affect the Th1 / Th2 balance, genotypes may be related to acute allograft rejection. Many studies have shown an association between cytokine gene polymorphisms and the development of several infections, allergies and autoimmune diseases. Also, associations between SNP in different cytokine genes and transplant rejection have been extensively studied. In our lab, SNP in the genes of TNF-α, TGF-β, IL- 4 and IL-10 were studied in a panel of 70 cardiac transplant patients and 61 of their donors. These data are discussed in the context of literature data.
Export Options
About this article
Cite this article as:
Bijlsma J. F., Bruggink H. A., Gmelig-Meyling H.J. F. and Weger de R.A., Cytokine Gene Polymorphism in Heart Transplantation: A Review, Current Genomics 2003; 4 (3) . https://dx.doi.org/10.2174/1389202033490411
DOI https://dx.doi.org/10.2174/1389202033490411 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Granulocyte Colony-Stimulating Factor (G-CSF) for Cardio- and Cerebrovascular Regenerative Applications
Current Medicinal Chemistry The Role of Colchicine in Pericardial Syndromes
Current Pharmaceutical Design Cancer Therapeutics-Related Cardiovascular Complications. Mechanisms, Diagnosis and Treatment
Current Pharmaceutical Design Targeting Potassium Channels: New Advances in Cardiovascular Therapy
Recent Patents on Cardiovascular Drug Discovery Current Problems with Non-Specific COX Inhibitors
Current Pharmaceutical Design Morphology of Atherosclerotic Plaque: Its Feature by Imaging Study
Current Pharmaceutical Design Remediation of Cellular Hypoxic Damage by Pharmacological Agents
Current Pharmaceutical Design Intra-Graft Abciximab and Verapamil Combined with Direct Stenting is a Safe and Effective Strategy to Prevent Slow-flow and No-Reflow Phenomenon in Saphenous Vein Graft Lesions not Associated with Thrombus
Recent Patents on Cardiovascular Drug Discovery A Review of Systemic Vasodilators in Low Cardiac Output Syndrome Following Pediatric Cardiac Surgery
Current Vascular Pharmacology Recent Patents and Advances on Isolation and Cellular Therapy Applications of Mesenchymal Stem Cells from Human Umbilical Cord Whartons Jelly
Recent Patents on Regenerative Medicine Aldosterone, From (Patho)Physiology to Treatment in Cardiovascular and Renal Damage
Current Vascular Pharmacology Biomarkers of Protein Oxidation in Human Disease
Current Molecular Medicine Biology of Cholesterol Lowering in Atherosclerotic Plaques
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Editorial: Recent developments in the Application of Separation and Hyphenated Techniques in Current Diagnostic Challenges
Current Medicinal Chemistry Molecular Basis of Mineralocorticoid Receptor Action in the Nervous System
CNS & Neurological Disorders - Drug Targets Cellular FLICE-Like Inhibitory Protein (C-FLIP): A Novel Target for Cancer Therapy
Current Cancer Drug Targets Efficacy of Cangrelor as Bridging Therapy Post PCI
Cardiovascular & Hematological Disorders-Drug Targets Editorial (No-reflow After Primary Coronary Interventions: How to Prevent and How to Treat it?)
Current Vascular Pharmacology Genomic and Non-genomic Effects of Aldosterone
Current Signal Transduction Therapy Mitochondrial Tolerance to Drugs and Toxic Agents in Ageing and Disease
Current Drug Targets